[EW] YoY Quarter Result on 30-Jun-2023 [#Q2]

Stock
[EW] Edwards Lifesciences Corporation
Announcement Date
28-Jul-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- -9.81%
YoY- -24.43%
Quarter Report
EW's Result
EW's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 1,385,900 1,530,200 1,373,900 1,376,000 925,000 1,086,900 943,700 6.60%
PBT 386,600 338,500 464,700 545,500 -168,200 271,300 251,000 7.45%
Tax 20,200 33,000 58,300 56,000 -46,300 29,000 -31,700 -
NP 366,300 307,100 406,400 489,500 -121,900 242,300 282,700 4.40%
Tax Rate -5.23% -9.75% -12.55% -10.27% - -10.69% 12.63% -
Total Cost 1,019,600 1,223,100 967,500 886,500 1,046,900 844,600 661,000 7.48%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin 26.43 20.07 29.58 35.57 -13.18 22.29 29.96 -2.06%
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS 0.61 0.51 0.65 0.79 -0.20 0.39 0.45 5.19%
EPS Diluted 0.61 0.50 0.65 0.78 -0.20 0.38 0.44 5.59%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.